Shares of SoftBank-backed Vir Biotechnology Inc plunged nearly 19.3% on their debut on Friday, adding to the gloom in the IPO market following WeWork’s failed attempt to list on the stock market.
Source:: Technology News
SoftBank-backed Vir Biotechnology’s shares tumble in market debut
More from Latest StoryMore posts in Latest Story »
- Nigel Slater’s recipes for kale, apple and peanuts, and pear shortcake tart
- Chicken Chili Supper: A Guide to Making the Perfect Meal
- Jeff Bezos defends decision to end Washington Post endorsements
- 10 years of the long read: Why Silicon Valley billionaires are prepping for the apocalypse in New Zealand (2018) – podcast
- Rumble in the Jungle 50 years on: how Ali danced rings around apartheid | Donald McRae
Be First to Comment